WO2015018124A1 - 一种降血压中药制剂及其制备方法 - Google Patents
一种降血压中药制剂及其制备方法 Download PDFInfo
- Publication number
- WO2015018124A1 WO2015018124A1 PCT/CN2013/085094 CN2013085094W WO2015018124A1 WO 2015018124 A1 WO2015018124 A1 WO 2015018124A1 CN 2013085094 W CN2013085094 W CN 2013085094W WO 2015018124 A1 WO2015018124 A1 WO 2015018124A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- chinese medicine
- blood pressure
- hawthorn
- uncaria
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 230000036772 blood pressure Effects 0.000 title claims abstract description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 29
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 29
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 29
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 29
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 29
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 29
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 29
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 29
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 29
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 29
- 241000157352 Uncaria Species 0.000 claims abstract description 27
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 24
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 23
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 19
- 241000208688 Eucommia Species 0.000 claims abstract description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 14
- 229930006000 Sucrose Natural products 0.000 claims abstract description 14
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract description 11
- 235000018905 epimedium Nutrition 0.000 claims abstract description 10
- 241000893536 Epimedium Species 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 3
- 241000258920 Chilopoda Species 0.000 claims abstract 7
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 7
- 238000003756 stirring Methods 0.000 claims abstract 3
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 24
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- 241000202726 Bupleurum Species 0.000 claims description 22
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 22
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 22
- 241000736199 Paeonia Species 0.000 claims description 20
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 20
- 241000207925 Leonurus Species 0.000 claims description 12
- 244000237330 gutta percha tree Species 0.000 claims description 11
- 235000010674 Prunella vulgaris Nutrition 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 7
- 241000336291 Cistanche deserticola Species 0.000 claims description 6
- 239000008669 duhuo Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 241000722949 Apocynum Species 0.000 claims 6
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims 3
- 235000003097 Artemisia absinthium Nutrition 0.000 claims 3
- 240000001851 Artemisia dracunculus Species 0.000 claims 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims 3
- 239000001138 artemisia absinthium Substances 0.000 claims 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 3
- 241000233866 Fungi Species 0.000 claims 2
- 241000212322 Levisticum officinale Species 0.000 claims 2
- 241000244365 Ligusticum sinense Species 0.000 claims 2
- 239000001645 levisticum officinale Substances 0.000 claims 2
- 235000003283 Pachira macrocarpa Nutrition 0.000 claims 1
- 240000005001 Paeonia suffruticosa Species 0.000 claims 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims 1
- 240000001085 Trapa natans Species 0.000 claims 1
- 235000014364 Trapa natans Nutrition 0.000 claims 1
- 235000009165 saligot Nutrition 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 21
- 230000003276 anti-hypertensive effect Effects 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 6
- 208000002173 dizziness Diseases 0.000 abstract description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 241000722948 Apocynum cannabinum Species 0.000 abstract 1
- 241000628997 Flos Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241001369613 Stephania tetrandra Species 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 22
- 206010020772 Hypertension Diseases 0.000 description 21
- 241000185686 Apocynum venetum Species 0.000 description 20
- 239000004575 stone Substances 0.000 description 15
- 244000126014 Valeriana officinalis Species 0.000 description 14
- 235000013832 Valeriana officinalis Nutrition 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 235000016788 valerian Nutrition 0.000 description 14
- 241000005787 Cistanche Species 0.000 description 12
- 206010036790 Productive cough Diseases 0.000 description 12
- 208000024794 sputum Diseases 0.000 description 12
- 210000003802 sputum Anatomy 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000003128 head Anatomy 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 7
- 208000012886 Vertigo Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 231100000889 vertigo Toxicity 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 241001016310 Epimedium grandiflorum Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 229930188301 Yinyanghuo Natural products 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- BKQVCDGQNOKQNF-KFFVICKMSA-N Corynoxine B Natural products O=C(OC)/C(=C\OC)/[C@@H]1[C@H](CC)C[N+]2[C@H]([C@@]3(C(=O)Nc4c3cccc4)CC2)C1 BKQVCDGQNOKQNF-KFFVICKMSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- VCNYNWHVJKWJRQ-UHFFFAOYSA-N Isorhynchophylline Natural products CCC1=CN2CCC3(C2CC1C(=COC)C(=O)OC)C(=O)Nc4ccccc34 VCNYNWHVJKWJRQ-UHFFFAOYSA-N 0.000 description 3
- DAXYUDFNWXHGBE-KAXDATADSA-N Rhynchophylline Chemical compound O=C1NC2=CC=CC=C2[C@@]11CCN2C[C@H](CC)[C@@H](\C(=C/OC)C(=O)OC)C[C@H]21 DAXYUDFNWXHGBE-KAXDATADSA-N 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 240000000073 Achillea millefolium Species 0.000 description 2
- 235000007754 Achillea millefolium Nutrition 0.000 description 2
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 231100000861 limb weakness Toxicity 0.000 description 2
- 208000027905 limb weakness Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241001632052 Haloxylon ammodendron Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001352116 Salix laevigata Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 analgesic Substances 0.000 description 1
- 239000000400 angiotensin II type 1 receptor blocker Substances 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003048 aphrodisiac agent Substances 0.000 description 1
- 230000002509 aphrodisiac effect Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Definitions
- the invention relates to a traditional Chinese medicine preparation for lowering blood pressure, in particular to a traditional Chinese medicine preparation for reducing blood pressure and a preparation method thereof.
- cardiovascular disease As a common disease in human body, cardiovascular disease has become one of the major factors threatening the health of today's human beings.
- cardiovascular disease has become one of the major factors threatening the health of today's human beings.
- the pace of life and work has accelerated, and the eating habits have developed toward high-heating and high-lipidity.
- the number of hypertensive patients in the population has been increasing year after year.
- the commonly used antihypertensive drugs in domestic hospitals mainly include calcium channel blockers (levels), ACE-I (Puli) and angiotensin-II (sartans).
- Drug-based, Western medicine lipid-lowering drugs are statins as the leading products.
- traditional Chinese medicine cardiovascular disease treatment preparations have gradually become the best-selling varieties in the domestic market.
- traditional Chinese medicine preparations have the characteristics of "multi-target, multi-effect". Because Chinese medicine theory believes that the human body is a whole, the traditional Chinese medicine for blood stasis has the ability to remove atherosclerotic plaque, dredge blood vessels and accelerate blood circulation.
- the object of the present invention is to provide a traditional Chinese medicine preparation for preventing and treating hypertension, based on the above-mentioned deficiencies, combined with modern Chinese and Western medicine technology, and in particular to provide such a traditional Chinese medicine preparation and a preparation method thereof.
- the invention belongs to a traditional Chinese medicine compound medicine for clearing heat and calming liver, dissolving blood stasis and promoting blood circulation, treating symptoms such as head vertigo caused by hypertension and liver yang sputum, and the invention can quickly achieve antihypertensive effect, and is non-toxic and has no side effects.
- the pressure drop is stable, the effect is stable, and the preparation process is simple and easy.
- the preparation of the invention is pure water, stone cassia, wild chrysanthemum, solo, eucommia, hawthorn, motherwort, yinyanghuo, defensive, apocynum venetum, peony bark, yarrow, uncaria, chuanxiong, bupleurum, prunella , a liquid preparation of a composition prepared from a solution of bismuth, white sugar and 65% ethanol, wherein the mass ratio of each component is:
- the preferred original mass ratio of the present invention is: pure water 5000-8000g stone cassia 10-20g wild chrysanthemum 20-30g ⁇ 20-30g Eucommia 25-30g Hawthorn 20_25g Motherwort 15-20g Cistanche 20-25g Anti-self 20_25g Apocynum venetum 20-25g Mudanpi 20-25g Valerian 30-35g Uncaria 30-35g Chuanxiong 20-25g Bupleurum 20- 25g Prunella 20-30g ⁇ 10_20g White sugar 20-30g
- the present invention can also be used as a preferred raw material quality with purified water 6000g stone cassia 15g wild chrysanthemum 25g
- the preparation method of the above blood pressure lowering traditional Chinese medicine preparation comprises the following steps:
- Decoction for half an hour add 2 times the amount of water for 20 minutes, add for the third time. Decoction for 5 minutes with 5 times the amount of water, then combine the decoction and filter, set aside;
- apocynum venetum, peony bark, valerian, uncaria, chuanxiong, Bupleurum, Prunella, and sputum are proportioned, crushed by a pulverizer and passed through a 80 mesh sieve, and then at 50-70 ° C Dry at high temperature, then naturally dry to room temperature for use;
- the prepared Chinese medicine composition solution preparation can be used for oral administration, and if it can be consumed once in the morning and evening and long-term drinking, the effect is better.
- the theoretical basis of the present invention is: stone cassia, which is a shell of abalone variegated abalone, abalone, auricular abalone, and abalone.
- stone cassia As a traditional Chinese medicine, it tastes salty, cold, and has the effects of clearing heat, calming, lowering blood pressure, and sympathetic nerves.
- the stone cassia is salty and cold, and the quality is heavy and yang. It is specialized in the liver, and it has the functions of Pingganyang and Qingganzhe. It is the medicine for Lianggan and Zhengan.
- Stone Cassia also uses liver and kidney yin deficiency, liver and yang vertigo, liver yang sputum, liver sputum, dizziness, headache, irritability and irritability, can be with Prunella, Uncaria, wild chrysanthemum, etc. use. Wild chrysanthemum, the head of the perennial herb of the Compositae, is similar to chrysanthemum. It is wild on the hillside grassland and on the side of the road. Wild chrysanthemum can be widely used for detoxification, treatment of acne swelling, sore throat, red eyes, headache and dizziness.
- the single-flavored decoction has a general effect, but it is very effective in combination with other traditional Chinese medicines of the present invention.
- Living alone is the dry root of the genus Umbelliferae. Mainly produced in Sichuan, Hubei, Anhui and other places. In the early spring or late autumn, remove the roots and sediment, simmer until half dry, stack for 2 to 3 days, soften and then simmer until dry, then slice and use.
- Eucommia ulmoides the dry bark of Eucommia ulmoides, is a valuable nourishing herb in China.
- Eucommia ulmoides tea with eucommia ulmoides as raw material has many functions such as nourishing liver and kidney, strengthening bones and muscles, lowering blood pressure and curing fetus.
- Eucommia ulmoides is sweet and warm, has the functions of tonifying the liver and kidney, strengthening the bones and strengthening the fetus, and reducing the blood pressure with the combination of Duhuo and Mudanpi, and lowering the blood pressure without coldness.
- Hawthorn an edible plant, stone fruit, hard, thin flesh, slightly sour.
- Hawthorn is a deciduous shrub. Branches dense, with fine thorns, young branches with pilose. Branchlets purple brown, old branches taupe.
- Hawthorn is a unique combination of fruit and fruit in China.
- Hawthorn can eliminate product, sputum, stagnation, hawthorn and sour lush, hawthorn can prevent cardiovascular disease, have dilated blood vessels, strong heart, increase coronary blood flow, improve heart vitality, excite the central nervous system, reduce blood Compression and cholesterol, softening blood vessels and diuresis and sedative effects; prevention and treatment of arteriosclerosis, anti-aging, anti-cancer effect.
- Hawthorn acid also has a strong heart effect and is also beneficial for senile heart disease.
- Motherwort the whole grass of the motherwort of the Labiatae family. Wei Xin; bitter; sexual micro-introduction, can promote blood, phlegm, menstruation, water.
- Cistanche deserticola is an endangered species of the genus Cistanche, alias ⁇ , ⁇ , Cistanche, Chagan yue (Mongolian).
- Cistanche deserticola is a parasitic plant that is parasitic in the desert tree Haloxylon ammodendron and roots of red willow. It is distributed in Inner Mongolia, Ningxia, Gansu and Xinjiang. It is known as "desert ginseng" and has high medicinal value. It is a traditional Chinese traditional medicine.
- Cistanche is rich in alkaloids, crystalline neutral substances, amino acids, trace elements, vitamins and other ingredients. It can replenish kidney yang and benefit essence blood, can inhibit the appearance of "yang deficiency" symptoms and prevent weight loss. Anti-self, bitter, cold. You can drink water and shed heat. Treatment of edema and swelling, hot and cold athlete's foot, hand and foot pain, hemorrhoids swollen. For edema athlete's foot, urinary adverse, eczema sore, rheumatic pain, high blood pressure and other symptoms.
- Apocynum venetum leaves leaves of Apocynum venetum, more shrinking and curling, some broken, can treat high blood pressure, Apocynum venetum decoction has antihypertensive effect; Apocynum venetum decoction has a strong heart effect; Apocynum venetum leaf extract has Calm, anticonvulsant, and have strong diuretic, lower blood lipids, and immune Mudanpi, a dried root bark of the peony of the Ranunculaceae. Produced in Anhui, Shandong and other places. In the autumn, the roots are excavated, the fine roots are removed, the root bark is peeled off, and dried. Raw or fried.
- Valerian annual herb, cold, sin, bitter, liver, kidney, rheumatoid arthritis, weakness, weak waist, limb paralysis, hemiplegia, rubella, other blood vessels and blood pressure It has hurricane and collaterals, clearing heat and reducing blood pressure, and can be used in combination with Eucommia for hypertension and rheumatism.
- Uncaria also known as the big hooked, double hooked vine, is the hooked vine of the genus Uncaria or the genus Hookus and its genus of various plants with hooked branches, climbing shrubs, unripe vines, sweet and slightly cold, can calm the liver De-fire and heat, can be used with liver yang sputum caused by dizziness, head pass, red eyes and other diseases, hook vine stems contain a variety of steroidal alkaloids, including rhynchophylline, isoflavone, Uncaria , as well as non-alkaloids.
- the main effective antihypertensive components in Uncaria are rhynchophylline and isoflavone, and the latter has a stronger antihypertensive effect than rhynchophylline.
- Chuanxiong a kind of traditional Chinese medicine plant, is often used for promoting blood circulation, relieving pain and relieving pain. It is mainly cultivated in Sichuan, Yunnan, Guizhou, Guangxi, Hubei and other places. Chuanxiong Xin Wenxiang dry, go without keeping, can not only disperse, up to the dome; and into the blood, down to blood.
- Activating blood circulation Pan suitable for blood stasis to block various diseases; hurricane pain, good effect, can cure head wind headache, rheumatism and pain.
- Chuanxiong was a gas medicine in the blood, and it was said that it had functions such as disintegration, depression, accessibility, and pain relief.
- Bupleurum, sexually cold, bitter taste, Xin return to the liver, gallbladder, with the effect of soothing liver and gallbladder, suffocating and relieving depression, scattered fire.
- Symptoms because it has a good ability to clear the liver and fire, can be taken or decoction, for hypertension is liver heat, impotence. It is a terrestrial arthropod.
- the body is composed of many body segments. Each section has a foot foot, so it is a multi-legged creature. They are fast and aggressive.
- 65% ethanol solution contains alcohol.
- Liquor is known as "the longest of 100 medicines”. The liquor is stable, safe and effective, and because alcohol is a good semi-polar organic solvent, the various active ingredients of traditional Chinese medicine are soluble. Among them, the medicine exerts its effectiveness by means of alcohol and alcohol to help the drug, and improves the therapeutic effect.
- hypertension is a pathological process in which blood pressure regulation disorders and systemic arterial blood pressure continue to rise.
- the diagnostic criteria for hypertension refer to an increase in arterial systolic and/or diastolic blood pressure (140/90 mm Hg) at rest, often accompanied by disorders of fat and glucose metabolism, and heart, brain, Functional or organic changes in organs such as the kidney and retina, systemic diseases characterized by organ remodeling.
- the blood pressure of 140/90mmHg measured on 2 different times on the same day can be diagnosed as hypertension.
- many hypertensive patients, especially obese, are often accompanied by diabetes, and diabetes is also associated with high blood pressure, so the two are called homologous diseases.
- People with diabetes have increased blood sugar, increased blood viscosity, damaged blood vessel walls, and increased vascular resistance, which may cause high blood pressure. It can be seen that both hypertension and diabetes are related to hyperlipidemia. Therefore, both hypertension and diabetes should lower blood pressure and regulate blood lipids.
- Chinese traditional Chinese medicine believes that hypertension is caused by emotional internal injuries, unhealthy diet, fatigue and fatigue, or due to old age, kidney loss, etc., leading to imbalance of yin and yang, wind and fire endogenous, phlegm and stasis, qi and blood Caused by chaos.
- Treatment is usually divided into the following types: liver yang upper sputum type, liver and kidney yin deficiency type, yin and yang deficiency type, turbid middle resistance type, congestion block type, rushing disorder type.
- Western medicine also treats high blood pressure, and Western medicine often has frequent additions and subtractions to achieve the target blood pressure. Therefore, blood pressure fluctuations often occur.
- the traditional Chinese medicine has a mild antihypertensive effect and a good blood pressure stabilization effect.
- the invention is particularly suitable for early, middle-aged and elderly hypertensive patients, and the heavier hypertension is combined with the traditional Chinese medicine treatment of the present invention, and can also prevent large blood pressure fluctuations.
- the oral liquid of the preparation of the present invention is taken 1 hour after the meal, 3 times a day, 300 ml each time, 1 month is a course of treatment, and two courses are observed as therapeutic effects.
- the oral liquid of the preparation of the present invention is taken 1 hour after the meal, 3 times a day, 300 ml each time, 1 month is a course of treatment, and two courses are observed as therapeutic effects.
- the beneficial effects of the present invention are that the preparation prepared by the invention can achieve the symptoms of clearing heat and calming the liver, removing blood stasis and promoting blood circulation, lowering blood pressure and treating head vertigo caused by liver yang sputum.
- the invention can quickly achieve the antihypertensive effect, and is non-toxic, has no side effects, has stable blood pressure, stable effect, and the preparation process is simple and easy.
- the preparation of the invention is pure water, stone cassia, wild chrysanthemum, solo, eucommia, hawthorn, motherwort, yinyanghuo, defensive, apocynum venetum, peony bark, yarrow, uncaria, chuanxiong, bupleurum, prunella , a liquid preparation of a composition prepared from a solution of bismuth, white sugar and 65% ethanol, wherein the mass ratio of each component is:
- the preparation method of the above blood pressure lowering traditional Chinese medicine preparation comprises the following steps:
- apocynum venetum, peony bark, valerian, uncaria, chuanxiong, Bupleurum, Prunella, and sputum are proportioned, crushed by a pulverizer and passed through a 80 mesh sieve, and then at 50-70 ° C Dry at high temperature, then naturally dry to room temperature for use;
- the preparation of the above-mentioned traditional Chinese medicine composition solution can be used for oral administration, and if it can be consumed once in the morning and evening and long-term drinking, the effect is better.
- Example 2 The preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the mass of each component is (g):
- the mass of each component is (g):
- the preparation method is as in Example 1.
- the mass of each component is (g):
- the preparation method is as in Example 1.
- the mass of each component is (g):
- the preparation method is as in Example 1.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Insects & Arthropods (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种降血压中药制剂及其制备方法。本发明制剂是由纯净水、石决明、野菊花、独活、杜仲、山楂、益母草、淫羊霍、防己、罗布麻叶、牡丹皮、豨莶草、钩藤、川芎、柴胡、夏枯草、蜈蚣、白糖和65%乙醇溶液经过粉碎、煎煮、混合、搅拌等工艺制备成的液态制剂。所述制剂,可以清热平肝,化痰活血,降低血压和治疗肝阳上亢引起的头部眩晕等症状,能够较快的达到降压效果,而且无毒,无副作用,降压平稳,效果稳定,制取工艺简便易行。
Description
一种降血压中药制剂及其制备方法 技术领域
本发明涉及一种降血压作用的中药制剂,具体的说是涉及这种降 血压作用的中药制剂及其制备方法。 背景技术
作为人身常见的一种疾病,心血管疾病已经成为威胁当今人类健 康的重大因素之一。近年来, 随着我国人口的老龄化以及人们生活水 平的提高, 生活、 工作节奏的加快, 饮食习惯向高热化、 高脂化方向 的发展, 人群中的高血压患者连年呈递增趋势。
目前, 针对降血压问题, 国内医院常用抗高血压药物主要以钙通 道阻滞剂(地平类)、 ACE— I (普利类)和血管紧张素酶一 II抑制(沙 坦类)三大类药物为主, 西药类降血脂药是他汀类为主导产品, 近些 年来中药类心血管病治疗制剂已逐渐成为国内市场上的畅销品种。与 西药制剂相比, 中药制剂具有 "多靶点、 多效应 "的特点, 因为中医 理论认为, 人体是一个整体, 故活血瘀类中药具有削除动脉粥样硬化 斑块, 疏通血管和加速血液循环等多种效果, 故中医类心血管病制剂 与作用单一的西药制剂相比更具优势。这表明我国广大病人对中药类 心血管制剂临床效果的认可,但目前市场上的中药药物治疗有些治标 不治本, 有些使用价格昂贵的成分, 很多产品降压效果不明显, 降压 后效果不稳定, 很容易反弹上升, 所述缺陷值得改进。
本发明的目的即在于针对上述不足, 在祖传秘方的基础上, 结合 现代中西医技术, 提供一种预防和治疗高血压的中药制剂, 具体的说 是提供这种中药制剂及其制备方法, 本发明属于一种清热平肝, 化痰 活血,主治高血压和肝阳上亢引起的头部眩晕等症状的中药复方药物, 本发明能够较快的达到降压效果, 而且无毒, 无副作用, 降压平稳, 效果稳定, 制取工艺简便易行。
本发明的技术方案如下所述:
本发明制剂是由纯净水、 石决明、 野菊花、 独活、 杜仲、 山楂、 益母草、 淫羊霍、 防己、 罗布麻叶、 牡丹皮、 豨莶草、 钩藤、 川芎、 柴胡、夏枯草、蜈蚣、白糖和 65%乙醇溶液制备成的组合物液态制剂, 其中各组分的质量配比为:
纯净水 4000-8000g 石决明 10- 30g 野菊花 20-40g 独活 20-40g 杜仲 25-35g 山楂 20- 30g 益母草 15-25g 肉苁蓉 20- 30g 防己 20-30g 罗布麻叶 20-30g 牡丹皮 20- 30g 豨莶草 30- 40g 钩藤 30-40g 川芎 20-30g 柴胡 20-30g 夏枯草 20-35g 蜈蚣 10- 20g 白糖 20-30g
65%乙醇溶液 15-30g。
为了获得更好的效果, 本发明可优选的原 质量配比为: 纯净水 5000-8000g 石决明 10— 20g 野菊花 20-30g
独活 20-30g 杜仲 25-30g 山楂 20_25g 益母草 15-20g 肉苁蓉 20-25g 防己 20_25g 罗布麻叶 20-25g 牡丹皮 20-25g 豨莶草 30-35g 钩藤 30-35g 川芎 20-25g 柴胡 20-25g 夏枯草 20-30g 蜈蚣 10_20g 白糖 20-30g
65%乙醇溶液 15-25g (
当然, 为了获得进一步好的效果, 本发明还可优选的原料质量配 纯净水 6000g 石决明 15g 野菊花 25g
独活 25g 杜仲 25g 山楂 20g
益母草 15g 肉苁蓉 20g 防己 20g
罗布麻叶 25g 牡丹皮 20g 豨莶草 30g
钩藤 30g 川芎 20g 柴胡 20g
夏枯草 25g 蜈蚣 15g 白糖 30g
65%乙醇溶液 20gc
上述降血压中药制剂的制备方法, 包括如下步骤:
1 )、 将石决明、 野菊花、 独活、 杜仲、 山楂、 益母草、 淫羊霍、 防己按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的 高温下烘干, 然后自然晾到室温备用;
2 )、将上述步骤中石决明、野菊花、独活、杜仲、 山楂、益母草、 淫羊霍、 防己的粉末混合物加入纯净水煎煮三次, 第一次加入 10倍
:水煎煮半个小时, 第二次加入 5倍量水煎煮 20分钟, 第三次加入
5倍量水煎煮 10分钟, 然后合并煎液并过滤, 备用;
3 )、将罗布麻叶、牡丹皮、豨莶草、钩藤、川芎、柴胡、夏枯草、 蜈蚣按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的 高温下烘干, 然后自然晾到室温备用;
4)、 将上述罗布麻叶、 牡丹皮、 豨莶草、 钩藤、 川芎、 柴胡、 夏 枯草、 蜈蚣的粉末混合物加入 10倍量的纯净水煎煮半个小时, 然后 取煎液并过滤, 备用;
5 )、 在室温状态下, 将上述步骤 2 ) 和步骤 4) 中获得的煎液混 合, 并加入 65%乙醇溶液并搅拌均匀, 形成中药组合物溶液制剂;
6 )、 将上述步骤 5 ) 中的中药组合物溶液制剂加入白糖, 并搅拌 5分钟, 即可制得。
制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚 各饮用一次并长期饮用, 效果更好。 本发明的理论依据在于: 石决明, 为鲍科动物杂色鲍、 皱纹盘鲍、 耳鲍、 羊鲍等的贝壳。 作为中药, 它味咸, 性寒, 有清热、 镇静、 降血压、 拟交感神经的作 用。 石决明咸寒清热, 质重潜阳, 专入肝经, 而有平肝阳、 清肝热之 功, 为凉肝、 镇肝之要药。 石决明还用治肝肾阴虚、 肝阳眩晕症, 肝 阳上亢、 肝火亢盛、 头晕头痛、 烦躁易怒者, 可与夏枯草、 钩藤、 野 菊花等清热、 平肝药物同用。
野菊花, 为菊科多年生草本植物野菊的头状花序, 外形与菊花相 似, 野生于山坡草地、 田边路旁。 野菊花可广泛用于清热解毒, 治疗 疔疮痈肿、 咽喉肿痛、 风火赤眼、 头痛眩晕等病证。 同时又有很好的 降压作用, 可用于高血压病的辅助治疗。 单味煎服效果一般, 但是与 本发明其他中药为伍, 则效果非常突出。 独活, 为伞形科植物重齿毛当归的干燥根。 主产于四川、 湖北、 安徽等地。 春初或秋末采挖, 除去须根及泥沙, 炕至半干, 堆置 2〜 3天,发软后再炕至全干,然后切片,生用。我国医书古籍《本草正》: "专理下焦风湿, 两足痛痹, 湿痒拘挛。 "独活味苦, 微温。 归肝、 肾、 膀胱经, 现代研究, 独活有抗炎、 镇痛及镇静作用, 对血小板聚 集有抑制作用, 并有降血压作用。 杜仲, 为杜仲科植物杜仲的干燥树皮, 是中国名贵滋补药材。 以 杜仲叶为原料的杜仲茶具补肝肾、强筋骨、降血压、安胎等诸多功效。 杜仲性味甘温, 有补肝肾、 强筋骨、 安胎降压效用, 与独活、 牡丹皮 等配伍可降血压, 且对体虚之人降血压无寒凉之弊。 山楂, 为可食用植物, 核果类水果, 质硬, 果肉薄, 味微酸涩。 山楂树是落叶灌木。 枝密生, 有细刺, 幼枝有柔毛。 小枝紫褐色, 老 枝灰褐色。 山楂是我国特有的药果兼用树种。 山楂可以消积, 行瘀, 化滞, 山楂味酸甘性微温, 山楂能防治心血管疾病, 具有扩张血管、 强心、 增加冠脉血流量、 改善心脏活力、 兴奋中枢神经***、 降低血
压和胆固醇、 软化血管及利尿和镇静作用; 防治动脉硬化, 防衰老、 抗癌的作用。 山楂酸还有强心作用, 对老年性心脏病也有益处。 益母草, 为唇形科植物益母草的全草。 味辛; 苦; 性微进, 可以 活血, 祛瘀, 调经, 消水。 治***, 胎漏难产, 胞衣不下, 产后 血晕, 瘀血腹痛, 崩中漏下, 尿血, 泻血, 痈肿疮疡等症。 肉苁蓉, 肉苁蓉属列当科濒危种, 别名大芸、 寸芸、 苁蓉、 查干 告亚(蒙语) 。 肉苁蓉是一种寄生在沙漠树木梭梭、 红柳根部的寄生 植物,分布于内蒙古、宁夏、甘肃和新疆,素有 "沙漠人参"之美誉, 具有极高的药用价值, 是我国传统的名贵中药材, 也是历代补肾壮阳 类处方中使用频度最高的补益药物之一。 肉苁蓉含有丰富的生物碱、 结晶性的中性物质、 氨基酸、 微量元素、 维生素等成分。 能补肾阳、 益精血, 能抑制 "阳虚"症状的出现, 防止体重减轻。 防己, 味苦, 寒。 可以行水, 泻下焦湿热。 治水肿臌胀, 湿热脚 气, 手足挛痛, 癣疥疮肿。 用于水肿脚气, 小便不利, 湿疹疮毒, 风 湿痹痛, 高血压等症。 罗布麻叶, 为罗布麻的叶子, 多皱缩卷曲, 有的破碎, 可以治疗 高血压, 罗布麻叶煎剂有降压作用; 罗布麻根煎剂有强心作用; 罗布 麻叶浸膏有镇静, 抗惊厥作用, 并有较强的利尿、 降低血脂、 调节免
牡丹皮, 为毛茛科植物牡丹干燥根皮。 产于安徽、 山东等地。 秋 季采挖根部, 除去细根, 剥取根皮, 晒干。 生用或炒用。 我国古代医 术《本草纲目》 : "滋阴降火, 解斑毒, 利咽喉, 通小便血滞。 后人 乃专以黄蘖治相火, 不知丹皮之功更胜也。 赤花者利, 白花者补, 人 亦罕悟, 宜分别之。 "现代研究, 所含牡丹酚及其以外的糖苷类成分 均有抗炎作用; 牡丹皮的甲醇提取物有抑制血小板作用; 牡丹酚有镇 静、 降温、 解热、 镇痛、 解痉等中枢抑制作用及抗动脉粥样硬化、 利 尿、 抗溃疡等作用。 豨莶草, 一年生草本, 寒、 辛、 苦, 归肝经、 肾经, 用于风湿关 节炎、 筋骨无力 、 腰膝酸软、 四肢麻痹、 半身不遂、 风疹湿疮, 另 有扩张血管以及降压功能,有祛风通络,清热降压作用,可同杜仲等配 伍,用于高血压及风湿病。 钩藤, 别名又叫大钩丁、 双钩藤, 为茜草科植物钩藤或华钩藤及 其同属多种植物的带钩枝条, 攀援状灌木, 钩藤味甘、 性微寒, 可以 平肝熄火清热, 可用与肝阳上亢所致的眩晕、 头通、 目赤等症, 钩藤 茎枝中含有多种吲哚类生物碱, 包括钩藤碱、 异钩藤碱、 钩藤总碱, 以及非生物碱。钩藤中主要有效降压成分为钩藤碱和异钩藤碱, 后者 的降压效果强于钩藤碱。 川芎, 一种中药植物, 常用于活血行气, 祛风止痛, 主要栽培于 四川、 云南、 贵州、 广西、 湖北等地。 川芎辛温香燥, 走而不守, 既 能行散, 上行可达巅顶; 又入血分, 下行可达血海。 活血祛瘀作用广
泛, 适宜瘀血阻滞各种病症; 祛风止痛, 效用甚佳, 可治头风头痛、 风湿痹痛等症。 昔人谓川芎为血中之气药, 殆言其寓辛散、 解郁、 通 达、 止痛等功能。 柴胡, 性微寒、 味苦、 辛、 归肝经、 胆经, 具疏肝利胆、 疏气解 郁、 散火之功效。 夏枯草, 味辛, 苦, 性寒, 有清肝泻火、 疏肝散结、 化痰、 降压 效用, 常用于治疗高血压病且伴有头痛、 目炫、 耳鸣、 烦热、 失眠等 症状, 因为其有精良清泄肝火效用, 可泡服或煎服, 用于高血压病属 肝热、 阳亢者。 蜈蚣为陆生节肢动物, 身体由许多体节组成, 每一节上均长有步 足, 故为多足生物。 它们行动迅速, 具攻击性。 在中医上, 蜈蚣归肝 经,能够息风镇痉,功毒散结,通络止痛。用于小儿惊风,抽搐痉挛, 中风口歪,半身不遂,破伤风,风湿顽痹,疮疡,瘰疬,毒蛇咬伤等。
65%乙醇溶液含酒精,白酒素有"百药之长"之称,白酒性质稳定、 安全有效, 而且因为酒精是一种良好的半极性有机溶剂, 中药的各种 有效成分都易溶于其中, 药借酒力、 酒助药势而充分发挥其效力, 提 高治疗效果。 众所周知, 高血压病是指血压调控障碍, 体循环动脉血压持续升 高的病理过程。 高血压的诊断标准是指在静息状态下动脉收缩压和 / 或舒张压增高( 140/90mmHg) ,常伴有脂肪和糖代谢紊乱以及心、脑、
肾和视网膜等器官功能性或器质性改变,以器官重塑为特征的全身性 疾病。休息 5分钟以上, 2次以上非同日测得的血压 140/90mmHg可 以诊断为高血压。临床上很多高血压病人特别是肥胖型常伴有糖尿病, 而糖尿病也较多的伴有高血压, 因此将两者称之同源性疾病。糖尿病 人由于血糖增高, 血粘稠度增加, 血管壁受损, 血管阻力增加, 易引 起高血压。 由此可知高血压与糖尿病都与高血脂有关, 因此防治高血 压病与糖尿病都应该同时降血压、 调节血脂。 我国中医认为, 高血压病是因情志内伤、 饮食不节、 劳倦损伤, 或因年老体衰, 肾精亏损等导致脏腑阴阳平衡失调, 风火内生, 痰淤 交阻, 气血逆乱所致。 治疗时通常分为以下几种类型: 肝阳上亢型、 肝肾阴虚型、 阴阳两虚型、 痰浊中阻型、 淤血阻滞型、 冲任失调型等 几种。 西药也治疗高血压,西医常常有为达到目标血压而频繁加减药量 等情况, 因此, 也常常出现血压波动幅度较大的现象。 而中药降压作 用缓和, 稳定血压效果较好, 本发明尤其适用于早期, 中老年高血压 患者, 较重的高血压病配合本发明的中药治疗, 也可防止血压较大波 动。 临床实验 1:
1 )、观察时间:在本发明技术方案未曾披露的情况下,选择 2013 年 1月到 2013年 3月的 3个月时间。
2 )、观察对象:在广东省深圳市中医院选择 10例病例:男 5例, 女 5例; 年龄: 45— 55岁 5例, 55— 75岁 5例; 职业: 民营企业主 5例, 退休人员 5例。 病程: 清晨测量血压不低于 150/100mmHg, 偶 有头部眩晕, 目视不清, 四肢无力症状。
3 )、 使用方法: 将本发明制剂口服液在餐后 1小时服用, 每日 3 次, 每次 300ml, 1个月为 1疗程, 两个疗程作为疗效观察。
4)、 观察效果:
在连续服用两个疗程后,其中 4例患者降至不高于 120/90mmHg, 3 例降至不高于 130/90mmHg, 3例降至不高于 110/90mmHg。 停药 7天后 观察, 没有明显反弹迹象, 血压平稳, 头部眩晕消失, 目视不清、 四 肢无力状况大大改善。
临床实验 2:
1 )、观察时间: 在本发明技术方案未曾披露的情况下, 选择 2013 年 4月到 2013年 6月的 3个月时间。
2 )、 观察对象: 在广东省深圳市福田区中医院选择 10例病例: 男 6例, 女 4例; 年龄: 55— 65岁 5例, 65— 75岁 5例; 职业: 曾 担任岗位领导的肥胖型公务员 5例, 肥胖型普通退休公务员 5例。病 程:清晨测量血压不低于 170/110mmHg,常伴随头部眩晕, 目视不清, 四肢无力症状。
3 )、 使用方法: 将本发明制剂口服液在餐后 1小时服用, 每日 3 次, 每次 300ml, 1个月为 1疗程, 两个疗程作为疗效观察。
4)、 观察效果:
在连续服用两个疗程后, 其中 4 例患者降至不高于 130/100mmHg, 3 例降至不高于 120/100mmHg, 3 例降至不高于 1 10/90mmHg o 停药 7天后观察, 没有明显反弹迹象, 血压平稳, 头部 眩晕消失, 目视不清、 四肢无力状况有所改善。
结合以上临床数据及本发明的理论依据,可见本发明有益效果在 于, 本发明制成的制剂, 可以达到清热平肝, 化痰活血, 降低血压和 治疗肝阳上亢引起的头部眩晕等症状,本发明能够较快的达到降压效 果,而且无毒,无副作用,降压平稳,效果稳定,制取工艺简便易行。 具体实舫式
下面结合实施例对本发明详细加以说明:
实施例 1:
本发明制剂是由纯净水、 石决明、 野菊花、 独活、 杜仲、 山楂、 益母草、 淫羊霍、 防己、 罗布麻叶、 牡丹皮、 豨莶草、 钩藤、 川芎、 柴胡、夏枯草、蜈蚣、白糖和 65%乙醇溶液制备成的组合物液态制剂, 其中各组分的质量配比为:
纯净水 4000g 石决明 10g 野菊花 20g
独活 20g 杜仲 25g 山楂 20g
益母草 15g 肉苁蓉 20g 防己 20g
罗布麻叶 20g 牡丹皮 20g 豨莶草 30g
钩藤 30g 川芎 20g 柴胡 20g
夏枯草 20g 蜈蚣 10g 白糖 20g
65%乙醇溶液 15g。
上述降血压中药制剂的制备方法, 包括如下步骤:
1 )、 将石决明、 野菊花、 独活、 杜仲、 山楂、 益母草、 淫羊霍、 防己按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的 高温下烘干, 然后自然晾到室温备用;
2 )、将上述步骤中石决明、野菊花、独活、杜仲、 山楂、益母草、 淫羊霍、 防己的粉末混合物加入纯净水煎煮三次, 第一次加入 10倍 量水煎煮半个小时, 第二次加入 5倍量水煎煮 20分钟, 第三次加入 5倍量水煎煮 10分钟, 然后合并煎液并过滤, 备用;
3 )、将罗布麻叶、牡丹皮、豨莶草、钩藤、川芎、柴胡、夏枯草、 蜈蚣按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的 高温下烘干, 然后自然晾到室温备用;
4)、 将上述罗布麻叶、 牡丹皮、 豨莶草、 钩藤、 川芎、 柴胡、 夏 枯草、 蜈蚣的粉末混合物加入 10倍量的纯净水煎煮半个小时, 然后 取煎液并过滤, 备用;
5 )、 在室温状态下, 将上述步骤 2 ) 和步骤 4) 中获得的煎液混 合, 并加入 65%乙醇溶液并搅拌均匀, 形成中药组合物溶液制剂;
6 )、 将上述步骤 5 ) 中的中药组合物溶液制剂加入白糖, 并搅拌 5分钟, 即可制得。
制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚 各饮用一次并长期饮用, 效果更好。
实施例 2:
本发明还可优选的原料质量为 (克):
纯净水 8000g 石决明 30g 野菊花 40g 独活 40g 杜仲 35g 山楂 30g 益母草 25g 肉苁蓉 30g 防己 30g 罗布麻叶 30g 牡丹皮 30g 豨莶草 40g 钩藤 40g 川芎 30g 柴胡 30g 夏枯草 35g 蜈蚣 20g 白糖 30g
65%乙醇溶液 15g。
制备方法如实施例 1。
实施例 3:
其中各组分的质量为 (克):
纯净水 5000g 石决明 15g 野菊花 25g 独活 25g 杜仲 30g 山楂 25g 益母草 20g 肉苁蓉 25g 防己 25g 罗布麻叶 25g 牡丹皮 25g 豨莶草 35g 钩藤 35g 川芎 25g 柴胡 25g 夏枯草 25g 蜈蚣 15g 白糖 25g 65%乙醇溶液 20g。
制备方法如实施例 1
实施例 4:
其中各组分的质量为 (克):
纯净水 6000g 石决明 20g 野菊花 30g
独活 30g 杜仲 35g 山楂 30g 益母草 25g 肉苁蓉 30g 防己 30g 罗布麻叶 30g 牡丹皮 30g 豨莶草 35g 钩藤 35g 川芎 30g 柴胡 30g 夏枯草 30g 蜈蚣 20g 白糖 30g 65%乙醇溶液 25gc
制备方法如实施例 1。
实施例 5:
其中各组分的质量为 (克):
纯净水 7000g 石决明 10g 野菊花 20g 独活 20g 杜仲 25g 山楂 20g 益母草 25g 肉苁蓉 30g 防己 30g 罗布麻叶 30g 牡丹皮 30g 豨莶草 30g 钩藤 30g 川芎 20g 柴胡 20g 夏枯草 35g 蜈蚣 20g 白糖 20g 65%乙醇溶液 30gc
制备方法如实施例 1。
实施例 6:
其中各组分的质量为 (克):
纯净水 4500g 石决明 12g 野菊花 28g 独活 28 杜仲 28g 山楂 26g 母草 18g 肉苁蓉 22g 防己 22g
罗布麻叶 22g 牡丹皮 22g 豨莶草 38g 钩藤 38g 川芎 21g 柴胡 21g
夏枯草 23g 蜈蚣 12g 白糖 28g
65%乙醇溶液 18g。
制备方法如实施例 1。
上述实施例仅是本发明众多实施方式的几种,如将各配方按技术方案
I大或减小药量, 制得的这种降血压制剂疗效并不受影响, 也将落在本发明的权利保护范围之内。
Claims
1、一种降血压中药制剂,其特征在于,本发明制剂是由纯净水、 石决明、 野菊花、 独活、 杜仲、 山楂、 益母草、 淫羊霍、 防己、 罗布 麻叶、 牡丹皮、 豨莶草、 钩藤、 川芎、 柴胡、 夏枯草、 蜈蚣、 白糖和
65%乙醇溶液制备成的组合物液态制剂, 其中各组分的质量配比为: 纯净水 4000- 8000g 石决明 10-30g 野菊花 20- 40g 独活 20-40g 杜仲 25-35g 山楂 20- 30g 益母草 15-25g 肉苁蓉 20-30g 防己 20-30g 罗布麻叶 20-30g 牡丹皮 20-30g 豨莶草 30- 40g 钩藤 30-40g 川芎 20-30g 柴胡 20- 30g 夏枯草 20-35g 蜈蚣 10-20g 白糖 20-30g
65%乙醇溶液 15- - 30g。
2、 根据权利要求 1 ,所述的降血压中药制剂, 其特征还在于, 纯净水 5000-8000g 石决明 10-20g 野菊花 20-30g 独活 20-30g 杜仲 25-30g 山楂 20-25g 益母草 15-20g 肉苁蓉 20-25g 防己 20-25g 罗布麻叶 20-25g 牡丹皮 20-25g 豨莶草 30-35g 钩藤 30-35g 川芎 20-25g 柴胡 20-25g 夏枯草 20-30g 蜈蚣 10_20g 白糖 20-30g
65%乙醇溶液 15-25g。
3、根据权利要求 1或 2所述的降血压中药制剂,其特征还在于,
其中各组分的质量配比为
纯净水 6000g 石决明 15g 野菊花 25g
独活 25g 杜仲 25g 山楂 20g
益母草 15g 肉苁蓉 20g 防己 20g
罗布麻叶 25g 牡丹皮 20g 豨莶草 30g
钩藤 30g 川芎 20g 柴胡 20g
夏枯草 25g 蜈蚣 15g 白糖 30g
65%乙醇溶液 20gc
4、 一种降血压中药制剂的制备方法, 其特征在于, 其包括如下
1 )、 将石决明、 野菊花、 独活、 杜仲、 山楂、 益母草、 淫羊霍、 防己按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的 高温下烘干, 然后自然晾到室温备用;
2 )、将上述步骤中石决明、野菊花、独活、杜仲、 山楂、益母草、 淫羊霍、 防己的粉末混合物加入纯净水煎煮三次, 第一次加入 10倍 量水煎煮半个小时, 第二次加入 5倍量水煎煮 20分钟, 第三次加入 5倍量水煎煮 10分钟, 然后合并煎液并过滤, 备用;
3 )、将罗布麻叶、牡丹皮、豨莶草、钩藤、川芎、柴胡、夏枯草、 蜈蚣按比例配好, 经过粉碎机粉碎并过 80目筛, 然后在 50— 70°C的 高温下烘干, 然后自然晾到室温备用;
4)、 将上述罗布麻叶、 牡丹皮、 豨莶草、 钩藤、 川芎、 柴胡、 夏 枯草、 蜈蚣的粉末混合物加入 10倍量的纯净水煎煮半个小时, 然后
取煎液并过滤, 备用;
5)、 在室温状态下, 将上述步骤 2 ) 和步骤 4) 中获得的煎液混 合, 并加入 65%乙醇溶液并搅拌均匀, 形成中药组合物溶液制剂; 6 )、 将上述步骤 5 ) 中的中药组合物溶液制剂加入白糖, 并搅拌 5分 钟, 即可制得, 制取的上述中药组合物溶液制剂可以用于口服, 如果 能够早中晚各饮用一次并长期饮用, 效果更好。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310343927.0A CN103417682B (zh) | 2013-08-09 | 2013-08-09 | 一种降血压中药制剂及其制备方法 |
CN201310343927.0 | 2013-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015018124A1 true WO2015018124A1 (zh) | 2015-02-12 |
Family
ID=49643423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/085094 WO2015018124A1 (zh) | 2013-08-09 | 2013-10-12 | 一种降血压中药制剂及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103417682B (zh) |
WO (1) | WO2015018124A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751334B (zh) * | 2014-01-02 | 2016-03-09 | 王静业 | 一种治疗高血压的药物及其制备方法 |
CN104013699B (zh) * | 2014-06-17 | 2015-05-06 | 梁存福 | 一种治疗肝阳上亢型高血压病的药物组合物 |
CN104490186B (zh) * | 2014-10-31 | 2016-02-24 | 马霞 | 一种具有降血压作用的中药枕 |
CN105831661A (zh) * | 2016-04-14 | 2016-08-10 | 梧州市产品质量检验所 | 一种降压龟苓膏及其制备方法 |
CN108686007A (zh) * | 2018-08-28 | 2018-10-23 | 深圳市必发达科技有限公司 | 一种降血脂的中药组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857584A (zh) * | 2006-03-14 | 2006-11-08 | 王信锁 | 一种治疗高血压的中药制剂 |
CN102293947A (zh) * | 2011-09-28 | 2011-12-28 | 曹文真 | 一种治疗高血压的中药 |
CN102526276A (zh) * | 2012-01-11 | 2012-07-04 | 张继述 | 一种降压药物组合物及其制备方法 |
CN102552724A (zh) * | 2012-01-11 | 2012-07-11 | 郑振宝 | 一种治疗高血压的中药组合物 |
-
2013
- 2013-08-09 CN CN201310343927.0A patent/CN103417682B/zh not_active Expired - Fee Related
- 2013-10-12 WO PCT/CN2013/085094 patent/WO2015018124A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857584A (zh) * | 2006-03-14 | 2006-11-08 | 王信锁 | 一种治疗高血压的中药制剂 |
CN102293947A (zh) * | 2011-09-28 | 2011-12-28 | 曹文真 | 一种治疗高血压的中药 |
CN102526276A (zh) * | 2012-01-11 | 2012-07-04 | 张继述 | 一种降压药物组合物及其制备方法 |
CN102552724A (zh) * | 2012-01-11 | 2012-07-11 | 郑振宝 | 一种治疗高血压的中药组合物 |
Non-Patent Citations (2)
Title |
---|
TANG, BUSHENG ET AL.: "Identification and Treatments Based on Traditional Chinese Medicine for Factors that Leading to Difficulty in Blood Pressure Control", LIAONING JOURNAL OF TRADITIONAL CHINESE MEDICINE, vol. 36, no. 2, 2009, pages 197 - 198 * |
WU, LIANGDE: "On Soothing the Liver by Using Radix Bupleuri to Treat Hypertension", JOURNAL OF SHANDONG COLLEGE OF TRADITIONAL CHINESE MEDICINE, no. 3, 1981, pages 26 * |
Also Published As
Publication number | Publication date |
---|---|
CN103417682B (zh) | 2014-09-17 |
CN103417682A (zh) | 2013-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102784363A (zh) | 一种治疗胰腺癌的中药组合物及其制备方法 | |
CN105194565A (zh) | 一种用于治疗心脏神经症的中药丸剂及制备方法 | |
WO2015018124A1 (zh) | 一种降血压中药制剂及其制备方法 | |
WO2015018129A1 (zh) | 一种降血压中药制剂及其制备方法 | |
CN107308097A (zh) | 一种化妆组成物 | |
CN104138529B (zh) | 一种降血脂中药制剂及其制备方法 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104127813A (zh) | 一种治疗气血两虚型褥疮的中药组合物及其制备方法 | |
WO2015018127A1 (zh) | 一种降血脂的中药制剂及其制备方法 | |
CN105687788A (zh) | 一种软化血管的药物组合物及其应用 | |
CN105435197A (zh) | 一种治疗桥本氏病的药物组合物及其制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN104398962A (zh) | 一种治疗脾肾两虚型腰肌劳损的中药组合物及其制备方法 | |
CN101249186A (zh) | 一种兼治外伤、风湿痛、牙痛的中药油剂及其生产方法 | |
KR20120024186A (ko) | 건강보조식품 조성물 및 그 제조방법 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN110384785A (zh) | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN104606638A (zh) | 一种治疗湿热型急性湿疹的药物及其制备方法 | |
CN104189192B (zh) | 治疗荨麻疹的中药药浴及制备方法 | |
CN113633700A (zh) | 一种治疗病毒性疣的药物配方及其制备方法 | |
CN105727050A (zh) | 一种治疗肝郁气滞型乳腺炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13890940 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01/07/2016) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13890940 Country of ref document: EP Kind code of ref document: A1 |